Nick Andrews
Nick Andrews
Verified email at phe.gov.uk
Title
Cited by
Cited by
Year
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study
E Miller, K Hoschler, P Hardelid, E Stanford, N Andrews, M Zambon
The Lancet 375 (9720), 1100-1108, 2010
8372010
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
CL Trotter, NJ Andrews, EB Kaczmarski, E Miller, ME Ramsay
The Lancet 364 (9431), 365-367, 2004
6962004
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study
E Miller, NJ Andrews, PA Waight, MPE Slack, RC George
The Lancet infectious diseases 11 (10), 760-768, 2011
6812011
Effectiveness of maternal pertussis vaccination in England: an observational study
G Amirthalingam, N Andrews, H Campbell, S Ribeiro, E Kara, K Donegan, ...
The Lancet 384 (9953), 1521-1528, 2014
6672014
Population‐based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40
WA Knowles, P Pipkin, N Andrews, A Vyse, P Minor, DWG Brown, E Miller
Journal of medical virology 71 (1), 115-123, 2003
5762003
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
PA Waight, NJ Andrews, SN Ladhani, CL Sheppard, MPE Slack, E Miller
The Lancet infectious diseases 15 (5), 535-543, 2015
5172015
Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
ME Ramsay, NJ Andrews, CL Trotter, EB Kaczmarski, E Miller
Bmj 326 (7385), 365-366, 2003
5012003
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity
MCJ Maiden, AB Ibarz-Pavůn, R Urwin, SJ Gray, NJ Andrews, SC Clarke, ...
The Journal of infectious diseases 197 (5), 737-743, 2008
4702008
Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study
B Taylor, E Miller, R Lingam, N Andrews, A Simmons, J Stowe
Bmj 324 (7334), 393-396, 2002
4692002
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England
ME Ramsay, N Andrews, EB Kaczmarski, E Miller
The lancet 357 (9251), 195-196, 2001
4292001
Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant.
J Lopez Bernal, N Andrews, C Gower, E Gallagher, R Simmons, ...
N Engl J Med, 585-594, 2021
419*2021
A statistical algorithm for the early detection of outbreaks of infectious disease
CP Farrington, NJ Andrews, AD Beale, MA Catchpole
Journal of the Royal Statistical Society: Series A (Statistics in Society†…, 1996
4041996
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study
NJ Andrews, PA Waight, P Burbidge, E Pearce, L Roalfe, M Zancolli, ...
The Lancet infectious diseases 14 (9), 839-846, 2014
3962014
Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox
M Brisson, NJ Gay, WJ Edmunds, NJ Andrews
Vaccine 20 (19-20), 2500-2507, 2002
3862002
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study
S de Lusignan, J Dorward, A Correa, N Jones, O Akinyemi, ...
The Lancet Infectious Diseases 20 (9), 1034-1042, 2020
3672020
A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012–2013
G Dabrera, G Amirthalingam, N Andrews, H Campbell, S Ribeiro, E Kara, ...
Clinical Infectious Diseases 60 (3), 333-337, 2015
3622015
Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection
R Borrow, N Andrews, D Goldblatt, E Miller
Infection and immunity 69 (3), 1568-1573, 2001
3492001
Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England
N Andrews, R Borrow, E Miller
Clinical and Vaccine Immunology 10 (5), 780-786, 2003
3392003
Statistical methods for the prospective detection of infectious disease outbreaks: a review
S Unkel, CP Farrington, PH Garthwaite, C Robertson, N Andrews
Journal of the Royal Statistical Society: Series A (Statistics in Society†…, 2012
3192012
Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis
E Miller, N Andrews, L Stellitano, J Stowe, AM Winstone, J Shneerson, ...
Bmj 346, 2013
3112013
The system can't perform the operation now. Try again later.
Articles 1–20